+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Sofosbuvir Use in the Setting of End-stage Renal Disease: A Single Center Experience



Sofosbuvir Use in the Setting of End-stage Renal Disease: A Single Center Experience



Journal of Clinical and Translational Hepatology 5(1): 23-26



Background and Aims: Patients with chronic hepatitis C (CHC) and end-stage renal disease (ESRD) who are dialysis-dependent form a unique group, in which safety, tolerability and efficacy of sofosbuvir (SOF)-based direct-acting antivirals (DAAs) need further evaluation. Methods: We performed a retrospective analysis of 14 patients with CHC and ESRD on dialysis who received 15 courses of SOF-based therapy. We evaluated dose escalation to standard-dose SOF in this proof-of-principle experience. Results: Sustained virological response (defined as undetectable viral load at 12 weeks, SVR-12) was achieved in 13 out of the 15 (86.7%) treatment courses. Seven (46.6%) patients received reduced half dose as conservative proof-of-principal to mitigate potential toxicity. In 13 out of 15 treatment courses, patients completed the designated treatment duration. One patient was treated twice and developed SVR-12 with the retreatment. One patient was lost to follow-up and counted as a non-responder. Premature discontinuations were not due to DAA-related adverse effects. There were no reports of severe adverse effects or drug interactions. Conclusion: We treated CHC patients with ESRD using dose escalation to standard-dose SOF in this proof-of-principle experience and achieved SVR rates comparable to general population.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 060262186

Download citation: RISBibTeXText

PMID: 28507922


Related references

Sofosbuvir Based Regimen in Management of Hepatitis C for Patients With End Stage Renal Disease on Hemodialysis: A Single Center Experience from India. Journal of Clinical and Experimental Hepatology 8(2): 116-120, 2018

Outcomes of renal transplantation after end-stage renal disease due to diabetic nephropathy: a single-center experience. Transplantation Proceedings 44(1): 77-79, 2012

Causes of end-stage renal disease in Sudan: a single-center experience. Saudi Journal of Kidney Diseases and Transplantation 22(2): 373-376, 2011

End-stage renal disease after kidney donation: a single-center experience. Transplantation Proceedings 40(5): 1315-1318, 2008

End-stage renal disease among living-kidney donors: single-center experience. Experimental and Clinical Transplantation 9(1): 14-19, 2011

Treatment of end-stage renal disease in a military setting: experience at Wilford Hall USAF Medical Center, 1977-1981. Military Medicine 148(5): 421-425, 1983

Impact of pre-end-stage renal disease education on peritoneal dialysis A single center experience. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 336A, 2001

Factors that influence progression of lupus nephritis to end stage renal disease A single center experience. Pediatric Research 37(4 PART 2): 358A, 1994

Single-Center Experience Providing Palliative Care to Pediatric Patients with End-Stage Renal Disease. Journal of Palliative Medicine 20(8): 845-849, 2017

A single center kidney transplant experience among ten Caucasian females with end-stage renal disease due to scleroderma
. Clinical Nephrology 88(1): 40-44, 2017

Cognitive function assessment in patients with end- stage renal disease in Nigeria: A single center experience. Annals of African Medicine 15(3): 138-144, 2017

Effectiveness and safety of sofosbuvir/ledipasvir ± ribavirin treatment in liver and/or renal transplant patients with chronic hepatitis C: A single-center experience. Sage Open Medicine 6: 2050312118781416, 2018

Kidney Transplantation in Korean Patients With End-Stage Renal Disease Aged 65 and Older: A Single-Center Experience. Transplantation Proceedings 49(5): 987-991, 2018

Kidney transplantation alone in end-stage renal disease patients with hepatitis B liver cirrhosis: a single-center experience. Transplantation 99(1): 133-138, 2015

Characteristics and Clinical Outcomes of End-Stage Renal Disease Patients on Peritoneal Dialysis for Over 15 Years: A Single-Center Experience. Peritoneal Dialysis International 37(5): 535-541, 2017